NASHVILLE, Tenn., July 17, 2017 -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced that on Wednesday evening, August 2, 2017, after the market closes, it expects to report results for the second quarter of 2017.
On August 3, 2017, at 9:00 a.m. Central Time, Healthcare Realty Trust expects to hold a conference call to discuss earnings results, quarterly activities, general operations of the Company and industry trends. Simultaneously, a webcast of the conference call will be available to interested parties via an Internet link at www.healthcarerealty.com under the Investor Relations section. A webcast replay will be available following the call at the same Internet site address.
Conference Call Details
Domestic Dial-In Number: 1.877.507.5522
International Dial-In Number: 1.412.317.6077
Replay Conference Call Details
Domestic Dial-In Number: 1.877.344.7529
International Dial-In Number: 1.412.317.0088
Conference ID: 10109671
Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of March 31, 2017, the Company had gross investments of approximately $3.5 billion in 195 real estate properties in 27 states totaling approximately 14.3 million square feet. The Company provided leasing and property management services to approximately 10.8 million square feet nationwide.
In addition to the historical information contained within, the matters discussed in this press release may contain forward-looking statements that involve risks and uncertainties. These risks are discussed in filings with the Securities and Exchange Commission by Healthcare Realty Trust, including its Annual Report on Form 10-K for the year ended December 31, 2016 under the heading “Risk Factors,” and as updated in its Quarterly Reports on Form 10-Q filed thereafter. Forward-looking statements represent the Company’s judgment as of the date of this release. The Company disclaims any obligation to update forward-looking statements.
Carla Baca Director of Corporate Communications P: 615.269.8175


Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
FDA Approves Mitapivat for Anemia in Thalassemia Patients
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit 



